S Etodolac contains S-Etodolac, a non-steroidal anti-inflammatory drug (NSAID) and the active S-enantiomer of etodolac. It is used to relieve pain, inflammation, and stiffness associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders, as well as for short-term management of acute pain. It works by reducing the production of prostaglandins, which are responsible for pain and inflammation in the body, and is typically available in oral tablet form.

S Etodolac contains S-Etodolac, the active S-enantiomer of etodolac, a non-steroidal anti-inflammatory drug (NSAID) used to help manage pain and inflammation. It belongs to the acetic acid derivative class of NSAIDs, and is commonly prescribed for conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal inflammatory disorders. It may also be used for short-term relief of acute pain when clinically appropriate.

It works by inhibiting cyclooxygenase (COX) enzymes involved in prostaglandin synthesis. Prostaglandins are key mediators of pain, inflammation, and swelling in the body. By reducing their production, S Etodolac may help decrease joint pain, stiffness, and swelling, thereby improving mobility and daily functioning in patients with inflammatory conditions.

S-Etodolac represents the pharmacologically active enantiomer of racemic etodolac, with most of the anti-inflammatory and analgesic activity attributed to the S-form. This stereoselective activity has been described in pharmacological literature and supports its therapeutic effect in pain and inflammation management.

Although S-Etodolac shows relative preference for COX-2 over COX-1 at therapeutic doses, it is not a fully selective COX-2 inhibitor. Therefore, gastrointestinal effects such as dyspepsia, ulceration, or bleeding may still occur, especially with prolonged use or in high-risk patients. Caution is also required in individuals with renal impairment, cardiovascular disease, or fluid retention risk. Safe use depends on taking it exactly as prescribed and only under a doctor’s guidance.

S Etodolac may be indicated by your doctor for:

Osteoarthritis (OA)

Relief of pain, stiffness, and inflammation associated with degenerative joint disease.

Rheumatoid Arthritis (RA)

Management of joint pain, swelling, and inflammation in autoimmune arthritis.

Juvenile Rheumatoid Arthritis (JRA)

Prescribed in children for controlling inflammation and improving mobility.

Acute Pain

Short‑term treatment of moderate pain, such as post‑surgical pain or musculoskeletal injuries.

Ankylosing Spondylitis (sometimes off‑label)

May be used to help reduce spinal pain and stiffness as advised by a doctor.

S Etodolac may provide benefits such as:

• Provides potent anti-inflammatory action by specifically targeting the S-isomer of the drug.

• Often carries a lower risk of stomach ulcers and gastrointestinal bleeding compared to non-selective NSAIDs.

• Effectively reduces morning stiffness and improves joint mobility in arthritis patients.

• Offers a long duration of action, typically allowing for convenient once or twice-daily dosing.

• Rapidly acts on acute pain, providing noticeable relief within an hour of administration.

• Helps decrease the need for other pain medications when used as part of a comprehensive management plan.

While S Etodolac is generally well-tolerated, it can cause side effects in some individuals.

Common side effects of S Etodolac may include

• Indigestion, heartburn, or stomach pain

• Nausea or bloating

• Dizziness or headache

• Diarrhoea or constipation

• Mild skin rash

Uncommon side effects of S Etodolac may include

• Ringing in the ears (tinnitus)

• Blurred vision

• Fatigue or drowsiness

• Swelling of the ankles or feet (oedema)

Serious side effects that may require immediate medical attention include

• Gastrointestinal Bleeding: Black, tarry stools or vomiting blood.

• Cardiovascular Events: Chest pain, shortness of breath, or sudden weakness on one side of the body.

• Kidney Stress: Significant changes in urine volume or blood in the urine.

• Severe Allergic Reaction: Swelling of the face or throat, severe hives, or difficulty breathing.

• Liver Issues: Yellowing of the skin/eyes (jaundice) or dark urine.

• Always consult your doctor if you notice any persistent or concerning reactions while taking S Etodolac.

Use S Etodolac exactly as directed by your doctor based on the prescribed form.

• Take the tablet with a full glass of water.

• It is recommended to take the dose with food or milk to reduce the risk of stomach upset.

• Swallow the tablet whole; do not crush or chew it unless specifically instructed otherwise.

• Try to take the medication at the same time each day to maintain consistent pain relief.

• If you are taking it for a chronic condition, do not stop taking it without consulting your doctor, as symptoms may return.

S Etodolac works by inhibiting the enzyme cyclooxygenase (COX). This enzyme is responsible for the synthesis of prostaglandins, which are lipid compounds that act as mediators of inflammation, pain, and fever. S-Etodolac specifically shows a higher affinity for COX-2, the enzyme primarily found at sites of inflammation, while having less impact on COX-1, which is involved in protecting the stomach lining. By reducing prostaglandin levels in the joints and tissues, it effectively decreases swelling and desensitises pain receptors.

• Always use the lowest dose as suggested by your doctor that relieves your pain to minimise the risk of side effects.

• Inform your doctor if you have a history of asthma, heart disease, or stomach ulcers before starting treatment.

• If you are on long-term therapy, your doctor may suggest regular blood tests to monitor your kidney and liver function.

• Avoid taking other NSAIDs (like Ibuprofen or Naproxen) or Aspirin while taking this medicine unless specifically advised, as it increases the risk of side effects.

• Stay well-hydrated to help support your kidney function while taking this medication.

• Store at room temperature in a cool, dry place.

• Protect from direct sunlight and moisture.

• Keep the tablets in their original blister pack or bottle.

• Keep out of the reach of children and pets.

• General Diet (MILD): Taking S Etodolac with food or milk can reduce stomach upset, but does not significantly change how the drug is absorbed.

• Alcohol (MODERATE): Alcohol increases the risk of stomach irritation, ulcers, and gastrointestinal bleeding when combined with S Etodolac. Limiting or avoiding alcohol is strongly advised.

• Anticoagulants (SEVERE): S Etodolac can significantly increase bleeding risk when taken with blood thinners such as Warfarin, Apixaban, or Heparin. Careful monitoring or avoidance is recommended.

• Other NSAIDs (SEVERE): Combining S Etodolac with other NSAIDs like Ibuprofen, Naproxen, or Aspirin raises the chance of gastrointestinal ulcers, bleeding, and kidney toxicity.

• Lithium (SEVERE): S Etodolac may reduce lithium clearance, leading to elevated blood levels and toxicity.

• Methotrexate (SEVERE): Reduced clearance of methotrexate can increase toxicity risk when used with S Etodolac.

• ACE Inhibitors / ARBs (MODERATE): Drugs such as Lisinopril or Losartan may have reduced blood pressure‑lowering effects and a higher risk of kidney impairment when combined with S Etodolac.

• Diuretics (MODERATE): Medicines like Furosemide or Hydrochlorothiazide may lose effectiveness and increase renal toxicity risk when taken with S Etodolac.

• Corticosteroids (MODERATE): Concurrent use of S Etodolac with Prednisone or Dexamethasone raises the risk of gastrointestinal bleeding.

• Asthma (SEVERE): NSAIDs like S Etodolac may trigger bronchospasm or worsen respiratory symptoms in sensitive individuals.

• Renal Impairment (SEVERE): S Etodolac can reduce kidney function and may worsen existing renal disease. Close monitoring is required.

• Gastrointestinal Disorders (SEVERE): Patients with ulcers or a history of GI bleeding are at high risk of complications such as perforation or haemorrhage.

• Cardiovascular Disease (MODERATE): S Etodolac may increase blood pressure, cause fluid retention, or raise the risk of heart attack and stroke.

• Liver Disease (MODERATE): Potential hepatotoxicity; liver function tests may be needed during treatment.

• Bleeding Disorders (CAUTION): S Etodolac may prolong clotting time and increase bleeding risk.

An overdose of S Etodolac can cause symptoms such as lethargy, drowsiness, nausea, vomiting, and epigastric pain. In severe cases, it can lead to high blood pressure, kidney failure, or respiratory depression. If an overdose is suspected, seek emergency medical care immediately.

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed one.